Quarterly report · Q1

Period2022-01-21 → 2022-04-20
Filed2022-06-03
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥34.8bn2022-01-21 → 2022-04-20Cons.Net sales
Revenue¥162.6bn2021-01-21 → 2022-01-20Cons.Net sales (5-year summary)
Revenue¥36.1bn2021-01-21 → 2021-04-20Cons.Net sales
Operating income−¥692m2022-01-21 → 2022-04-20Cons.Operating income
Operating income¥426m2021-01-21 → 2021-04-20Cons.Operating income
Ordinary income−¥585m2022-01-21 → 2022-04-20Cons.Ordinary income
Ordinary income¥5.7bn2021-01-21 → 2022-01-20Cons.Ordinary income loss (5-year summary)
Ordinary income¥400m2021-01-21 → 2021-04-20Cons.Ordinary income
Profit before tax−¥676m2022-01-21 → 2022-04-20Cons.Income before income taxes
Profit before tax¥431m2021-01-21 → 2021-04-20Cons.Income before income taxes
Net income (owners)−¥857m2022-01-21 → 2022-04-20Cons.Profit loss attributable to owners of parent
Net income (owners)¥4.0bn2021-01-21 → 2022-01-20Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥229m2021-01-21 → 2021-04-20Cons.Profit loss attributable to owners of parent
Net income−¥860m2022-01-21 → 2022-04-20Cons.Profit loss
Net income¥217m2021-01-21 → 2021-04-20Cons.Profit loss
Total assets¥163.8bnat 2022-04-20Cons.Assets
Total assets¥159.0bnat 2022-01-20Cons.Assets
Total assets¥163.5bnat 2021-04-20Cons.Total assets (5-year summary)
Total liabilities¥82.1bnat 2022-04-20Cons.Liabilities
Total liabilities¥75.7bnat 2022-01-20Cons.Liabilities
Net assets / equity¥81.7bnat 2022-04-20Cons.Net assets
Net assets / equity¥83.3bnat 2022-01-20Cons.Net assets
Net assets / equity¥83.8bnat 2021-04-20Cons.Net assets (5-year summary)
Cash and deposits¥27.4bnat 2022-04-20Cons.Cash and deposits
Cash and deposits¥27.6bnat 2022-01-20Cons.Cash and deposits
EPS (basic)¥-54.782022-01-21 → 2022-04-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥254.22021-01-21 → 2022-01-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥14.722021-01-21 → 2021-04-20Cons.Basic earnings loss per share (5-year summary)
Equity ratio49.6%at 2022-04-20Cons.Equity to asset ratio (5-year summary)
Equity ratio52.1%at 2022-01-20Cons.Equity to asset ratio (5-year summary)
Equity ratio51.0%at 2021-04-20Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-01-21 → 2022-04-20−¥134m
Reconciling Itemsreconcilingrevenue intersegment2022-01-21 → 2022-04-20−¥134m
Reconciling Itemsreconcilingsegment profit2022-01-21 → 2022-04-20−¥270m
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentrevenue2022-01-21 → 2022-04-20¥24.8bn
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2022-01-21 → 2022-04-20¥24.8bn
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2022-01-21 → 2022-04-20¥12m
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2022-01-21 → 2022-04-20−¥325m
jpcrp040300-q1r_E00424-000Dy Do Pharmareportable segmentsegment profit2022-01-21 → 2022-04-20−¥96m
jpcrp040300-q1r_E00424-000Food Businessreportable segmentrevenue2022-01-21 → 2022-04-20¥4.3bn
jpcrp040300-q1r_E00424-000Food Businessreportable segmentrevenue external2022-01-21 → 2022-04-20¥4.3bn
jpcrp040300-q1r_E00424-000Food Businessreportable segmentrevenue intersegment2022-01-21 → 2022-04-20¥1m
jpcrp040300-q1r_E00424-000Food Businessreportable segmentsegment profit2022-01-21 → 2022-04-20¥234m
jpcrp040300-q1r_E00424-000International Beverage Businessreportable segmentrevenue2022-01-21 → 2022-04-20¥3.0bn
jpcrp040300-q1r_E00424-000International Beverage Businessreportable segmentrevenue external2022-01-21 → 2022-04-20¥3.0bn
jpcrp040300-q1r_E00424-000International Beverage Businessreportable segmentsegment profit2022-01-21 → 2022-04-20−¥205m
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2022-01-21 → 2022-04-20¥2.9bn
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2022-01-21 → 2022-04-20¥2.7bn
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2022-01-21 → 2022-04-20¥120m
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2022-01-21 → 2022-04-20−¥28m
—segment totalrevenue2022-01-21 → 2022-04-20¥34.9bn
—segment totalrevenue external2022-01-21 → 2022-04-20¥34.8bn
—segment totalrevenue intersegment2022-01-21 → 2022-04-20¥134m
—segment totalsegment profit2022-01-21 → 2022-04-20−¥422m
Reconciling Itemsreconcilingrevenue2021-01-21 → 2021-04-20−¥126m
Reconciling Itemsreconcilingrevenue intersegment2021-01-21 → 2021-04-20−¥126m
Reconciling Itemsreconcilingsegment profit2021-01-21 → 2021-04-20−¥367m
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentrevenue2021-01-21 → 2021-04-20¥26.9bn
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2021-01-21 → 2021-04-20¥26.9bn
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2021-01-21 → 2021-04-20¥15m
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2021-01-21 → 2021-04-20¥707m
jpcrp040300-q1r_E00424-000Dy Do Pharmareportable segmentsegment profit2021-01-21 → 2021-04-20−¥44m
jpcrp040300-q1r_E00424-000Food Businessreportable segmentrevenue2021-01-21 → 2021-04-20¥4.3bn
jpcrp040300-q1r_E00424-000Food Businessreportable segmentrevenue external2021-01-21 → 2021-04-20¥4.3bn
jpcrp040300-q1r_E00424-000Food Businessreportable segmentrevenue intersegment2021-01-21 → 2021-04-20¥1m
jpcrp040300-q1r_E00424-000Food Businessreportable segmentsegment profit2021-01-21 → 2021-04-20¥143m
jpcrp040300-q1r_E00424-000International Beverage Businessreportable segmentrevenue2021-01-21 → 2021-04-20¥2.4bn
jpcrp040300-q1r_E00424-000International Beverage Businessreportable segmentrevenue external2021-01-21 → 2021-04-20¥2.4bn
jpcrp040300-q1r_E00424-000International Beverage Businessreportable segmentsegment profit2021-01-21 → 2021-04-20−¥30m
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2021-01-21 → 2021-04-20¥2.7bn
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2021-01-21 → 2021-04-20¥2.6bn
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2021-01-21 → 2021-04-20¥109m
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2021-01-21 → 2021-04-20¥17m
—segment totalrevenue2021-01-21 → 2021-04-20¥36.3bn
—segment totalrevenue external2021-01-21 → 2021-04-20¥36.1bn
—segment totalrevenue intersegment2021-01-21 → 2021-04-20¥126m
—segment totalsegment profit2021-01-21 → 2021-04-20¥793m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 393
ItemContextValueUnit
Remeasurements of defined benefit plansCurrentQuarterInstant228000000JPY
Valuation and translation adjustmentsPrior1YearInstant-5970000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant-6376000000JPY
Non controlling interestsPrior1YearInstant450000000JPY
Non controlling interestsCurrentQuarterInstant455000000JPY
Net assetsPrior1YearInstant83261000000JPY
Net assetsCurrentQuarterInstant81722000000JPY
Liabilities and net assetsPrior1YearInstant158984000000JPY
Liabilities and net assetsCurrentQuarterInstant163808000000JPY
Net salesPrior1YTDDuration36150000000JPY
Net salesCurrentYTDDuration34795000000JPY
Cost of salesPrior1YTDDuration16834000000JPY
Cost of salesCurrentYTDDuration18435000000JPY
Gross profitPrior1YTDDuration19316000000JPY
Gross profitCurrentYTDDuration16360000000JPY
Selling general and administrative expensesPrior1YTDDuration18889000000JPY
Selling general and administrative expensesCurrentYTDDuration17052000000JPY
Operating incomePrior1YTDDuration426000000JPY
Operating incomeCurrentYTDDuration-692000000JPY
Interest income noiPrior1YTDDuration60000000JPY
Interest income noiCurrentYTDDuration21000000JPY
Dividends income noiPrior1YTDDuration2000000JPY
Dividends income noiCurrentYTDDuration3000000JPY
Gain on valuation of investment securities noiPrior1YTDDuration-JPY
Gain on valuation of investment securities noiCurrentYTDDuration68000000JPY
Other noiPrior1YTDDuration119000000JPY
Other noiCurrentYTDDuration127000000JPY
Non operating incomePrior1YTDDuration182000000JPY
Non operating incomeCurrentYTDDuration220000000JPY
Interest expenses noePrior1YTDDuration70000000JPY
Interest expenses noeCurrentYTDDuration48000000JPY
Equity in losses of affiliates noePrior1YTDDuration13000000JPY
Equity in losses of affiliates noeCurrentYTDDuration17000000JPY
Foreign exchange losses noePrior1YTDDuration82000000JPY
Foreign exchange losses noeCurrentYTDDuration-JPY
Loss on retirement of noncurrent assets noePrior1YTDDuration10000000JPY
Loss on retirement of noncurrent assets noeCurrentYTDDuration33000000JPY
Other noePrior1YTDDuration31000000JPY
Other noeCurrentYTDDuration13000000JPY
Non operating expensesPrior1YTDDuration208000000JPY
Non operating expensesCurrentYTDDuration112000000JPY
Ordinary incomePrior1YTDDuration400000000JPY
Ordinary incomeCurrentYTDDuration-585000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration44000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration-JPY
Gain on sales of investment securities eiPrior1YTDDuration4000000JPY
Gain on sales of investment securities eiCurrentYTDDuration-JPY
Extraordinary incomePrior1YTDDuration49000000JPY
Extraordinary incomeCurrentYTDDuration-JPY
Loss on disaster elPrior1YTDDuration18000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-01-20pass rounding
balance sheet identityconsolidated 2022-04-20pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-01-20pass
statement vs summary · net assetsconsolidated 2022-04-20pass
statement vs summary · net income attributable to parentconsolidated 2021-01-21/2021-04-20pass
statement vs summary · net income attributable to parentconsolidated 2022-01-21/2022-04-20pass
statement vs summary · revenueconsolidated 2021-01-21/2021-04-20pass
statement vs summary · revenueconsolidated 2022-01-21/2022-04-20pass
statement vs summary · total assetsconsolidated 2022-01-20pass
statement vs summary · total assetsconsolidated 2022-04-20pass